Skip to main content
. 2021 May 4;37(4):730–736. doi: 10.1007/s11606-021-06834-1

Figure 1.

Figure 1

a Breakdown of study participants (n=308,664) by frailty categories based on oral anticoagulation prescription status. b Breakdown of study participants (n=121,839) by frailty categories based on the type of oral anticoagulation prescribed. OAC, oral anticoagulation; VKA, vitamin K antagonist; DOAC, direct oral anticoagulant.